Drug recall · April 3, 2024
PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride Injection recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 5 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-11-K, Bar Code 70004081011. (same finished product as F078140, but with RFID for KitCheck
- Lots / codes
Lot #: 1223048431 exp 04/05/24; 1223049023 exp 04/25/24
- Quantity
- 1,118 syringes in kits
- Company
- SCA Pharmaceuticals, LLC, Windsor, CT
- Distribution
- Nationwide in the USA
- Initiated
- November 9, 2023 · Voluntary: Firm initiated
- Classified
- March 22, 2024
- Reported
- April 3, 2024
- Ended
- August 27, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenylephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.